CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in patients with stemi treated by prasugrel or ticagrelor
Machal, J., Hlinomaz, O., Kostolanska, K., Pes, O., Machalova, A., Jurica, J.Volume:
275
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2018.06.246
Date:
August, 2018
File:
PDF, 278 KB
english, 2018